Manabe Tadashi

マナベタダシ | Manabe Tadashi

Affiliation and department：

Research keywords (4)： Developing new targeted therapies , MAPK signaling in lung cancer , Drug resistance mechanisms in lung cancer , Establishment of patient-derived cancer models

Research theme for competitive and other funds (3)：

2021 - 2022 Elucidation of the resistant mechanism of molecular inhibitors using lung cancer organoids
2019 - 2021 Development of precision medicine for molecular inhibitor resistant patients using patient-derived cancer cell lines
2017 - 2019 Identification of treatable tyrosine kinases for both lung cancer and interstitial pneumonia.

Papers (38)：

Tadashi Manabe, Trever G Bivona. Remodeling of the tumor/tumor microenvironment ecosystem during KRAS G12C inhibitor clinical resistance in lung cancer. The Journal of clinical investigation. 2022. 132. 4
Kensuke Nakagawara, Ho Namkoong, Hideki Terai, Katsunori Masaki, Takae Tanosaki, Kyoko Shimamoto, Ho Lee, Hiromu Tanaka, Satoshi Okamori, Hiroki Kabata, et al. Comprehensive and long-term surveys of COVID-19 sequelae in Japan, an ambidirectional multicentre cohort study: study protocol. BMJ open respiratory research. 2021. 8. 1
石岡宏太, 安田浩之, 浜本純子, 寺井秀樹, 荒井大輔, 扇野圭子, 谷哲夫, 増澤啓太, 真鍋維志, 篠崎太郎, et al. FGF9による肺腺癌の小細胞癌化に関する検討. 肺癌. 2021. 61. 6. 651-651
石岡宏太, 安田浩之, 浜本純子, 寺井秀樹, 荒井大輔, 扇野圭子, 谷哲夫, 増澤啓太, 真鍋維志, 篠崎太郎, et al. FGF9による肺腺癌の小細胞癌化に関する検討. 肺癌. 2021. 61. 6. 651-651
Kota Ishioka, Hiroyuki Yasuda, Junko Hamamoto, Hideki Terai, Katsura Emoto, Tae-Jung Kim, Shigemichi Hirose, Takashi Kamatani, Sachiyo Mimaki, Daisuke Arai, et al. Upregulation of FGF9 in Lung Adenocarcinoma Transdifferentiation to Small Cell Lung Cancer. Cancer research. 2021. 81. 14. 3916-3929

ｍore...

MISC (13)：

眞鍋維志. みんなで解決! 病棟のギモン研修医の素朴な質問にお答えします(第47回) プレゼンテーションの技法と作法. レジデントノート. 2020. 21. 16. 2866-2871
眞鍋維志, 安田浩之, 小林慧悟, 増澤啓太, 浜本純子, 寺井秀樹, 川田一郎, 副島研造. 患者由来肺癌細胞株の樹立とチロシンキナーゼ阻害薬耐性化機序の解明(Establishment of patient-derived cancer cell lines to elucidate the resistant mechanism of tyrosine kinase inhibitors). 日本癌学会総会記事. 2019. 78回. E-3097
眞鍋維志, 杉原快, 光石彬史, 胡谷俊樹, 竹原朋宏, 小林慧悟, 増澤啓太, 池村辰之介, 寺井秀樹, 安田浩之, et al. 肺癌基礎分子標的薬耐性化後の患者検体を用いた肺癌細胞株の樹立と耐性化機序の解明. 日本呼吸器学会誌. 2019. 8. 増刊. 162-162
眞鍋維志, 副島研造. 【がん診療における心血管合併症:onco-cardiologyアップデート】内科で診る機会の多い腫瘍の化学療法と心血管合併症について知る肺癌. 診断と治療. 2018. 106. 8. 957-961
眞鍋維志, 胡谷俊樹, 竹原朋宏, 小林慧悟, 増澤啓太, 長谷川華子, 安田浩之, 川田一郎, 猶木克彦, 副島研造, et al. 分子標的薬耐性化後の胸水・腹水検体を用いた癌細胞株の樹立と耐性化機序の解明. 日本呼吸器学会誌. 2018. 7. 増刊. 174-174

ｍore...

Education (2)：

2017 - 2020 Keio University Graduate School of Medicine Doctoral course (Medicine)
2006 - 2012 Keio University School of Medicine

Professional career (2)：

MD (Keio University School of Medicine)
PhD (Keio University Graduate School of Medicine)

Work history (5)：

2021/04 - 現在 University of California, San Francisco Department of Medicine, Division of Hematology/Oncology Postdoctoral Scholar-Fellow
2020/04 - 2021/03 Tachikawa Hospital Department of Internal Medicine, Division of Pulmonary Medicine Medical Staff
2017/04 - 2020/03 Keio University School of Medicine Department of Internal Medicine, Division of Pulmonary Medicine Assistant Professor (Fellow)
2014/04 - 2018/03 Keio University School of Medicine Department of Internal Medicine Senior Resident
2012/04 - 2014/03 Keio University Hospital Junior Resident

Awards (2)：

2022/07 - Damon Runyon Cancer Research Foundation Fellowship Award
2022/02 - International Association for the Study of Lung Cancer (IASLC) Education Award Best Fellows Oral Abstract Session

Association Membership(s) (8)：

International Association for the Study of Lung Cancer , American Association for Cancer Research , Japanese Society of Medical Oncology , The Japan Lung Cancer Society , The Japanese Respiratory Society , Japanese Society of Respiratory Endoscopy , The Japanese Society of Internal Medicine , Japanese Cancer Association

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page